NCT00005830View on ClinicalTrials.gov

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

July 31, 2009

Conditions
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous AdenocarcinomaStage III Uterine Corpus CancerStage IV Uterine Corpus Cancer
Interventions
DRUG

Doxorubicin Hydrochloride

Given IV

DRUG

Cisplatin

Given IV

RADIATION

Radiation Therapy

Undergo radiation therapy

Trial Locations (1)

19103

Gynecologic Oncology Group, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00005830 - Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer | Biotech Hunter | Biotech Hunter